Pharimexco reports business targets for 2008

Friday, May 23, 2008
Cuu Long Pharmaceutical Product Joint Stock Co (Pharimexco) reported gaining 367 billion dong in revenue, 43 billion in after-tax profit and ratio of profit on chartered capital of 53%, and a dividend of 20% including 10% in cash and 10% in shares in 2007. The figures are expected to reach 745 billion, 57.15 billion and a dividend of 20% also this year.

In 2008, the company plans to offer 810,000 shares at 10,000 dong par for 10% dividend of 2007, another 810,000 bonus shares, sell 405,000 shares to existing shareholders in line with the ratio of 20:1, another 405,000 shares to key employees and 1,070,000 shares to external shareholders. The share offering aims to hike the company's chartered capital from 81 billion dong to 116 billion dong.